AVDL

AVDL

USD

Avadel Pharmaceuticals plc Ordinary Share

$18.780+0.030 (0.160%)

Precio en Tiempo Real

Healthcare
Drug Manufacturers - Specialty & Generic
Irlanda

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$18.750

Máximo

$18.780

Mínimo

$18.680

Volumen

1.08M

Fundamentos de la Empresa

Capitalización de Mercado

1.8B

Industria

Drug Manufacturers - Specialty & Generic

País

Ireland

Estadísticas de Negociación

Volumen Promedio

2.43M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $6.38Actual $18.780Máximo $19.06

Noticias Relacionadas

Analyst Upgrades

UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals from Buy to Neutral and maintains the price target from $20 to $20.

Ver más
UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20
Analyst Upgrades

Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals from Outperform to Market Perform and announces $18.5 price target.

Ver más
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Ver más
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
PR Newswire

HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Ver más
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
Analyst Upgrades

Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals from Buy to Hold and lowers the price target from $22 to $20.

Ver más
Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20
Analyst Upgrades

Needham Downgrades Avadel Pharmaceuticals to Hold

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals from Buy to Hold.

GlobeNewswire

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.